ArticleFrontiers in neurology
Efficacy and safety of warm acupuncture in oxaliplatin-induced chronic peripheral neuropathy: a multicentre, randomized controlled trial protocol.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oxaliplatin-induced chronic peripheral neuropathy (OICPN) is a prevalent side effect experienced by patients receiving chemotherapy that primarily manifests as ongoing numbness in the limbs that can persist after treatment ends. This condition significantly diminishes quality of life and frequently leads to dose reduction or early treatment cessation, compromising antitumor efficacy. However, a universally accepted and effective approach for the prevention or treatment of OICPN is currently unavailable. In our clinical observations, we have noted that warm acupuncture may relieve the symptoms of patients experiencing OICPN. Consequently, we propose this randomized controlled trial (RCT) to rigorously assess the safety and effectiveness of warm acupuncture for OICPN patients with the goal of providing preliminary evidence for its use in clinical settings. Methods and analysis: This study is a multicentre, randomized, controlled clinical trial involving 84 patients diagnosed with OICPN. Participants will be randomly divided into two groups in a 1:1 ratio to receive either standard care alone or warm acupuncture plus standard care. This regimen will include 16 sessions, with treatments occurring twice a week for the first month and once a week for the subsequent 2 months. All participants will complete the 12-week program and one-year follow-up. Outcomes will be assessed by blinded evaluators. The primary outcome is neurotoxicity graded by the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 4.0. Secondary outcomes include the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-item scale (EORTC QLQ-CIPN20) and the European Organization for Research and Treatment of Cancer Quality of Life Core 30 Questionnaire (EORTC QLQ-C30), measured at baseline, week 2, month 1, post-treatment, and during follow-up. Clinical trial registration: https://www.chictr.org.cn/index.html, ChiCTR2400082506.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.